These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 21950193)

  • 21. Humoral immune responses among mucosal and cutaneous leishmaniasis patients caused by Leishmania braziliensis.
    Valli LC; Passos VM; Dietze R; Callahan HL; Berman JD; Grogl M
    J Parasitol; 1999 Dec; 85(6):1076-83. PubMed ID: 10647040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.
    Tonui WK; Mbati PA; Anjili CO; Orago AS; Turco SJ; Githure JI; Koech DK
    East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination of different strains of mice against cutaneous leishmaniosis: usefulness of membrane antigens encapsulated into liposomes by intraperitoneal and subcutaneous administration.
    Lezama-Dávila CM
    Arch Med Res; 1997; 28(1):47-53. PubMed ID: 9078587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of ELISA employing Leishmania (Viannia) braziliensis and Leishmania (Leishmania) chagasi antigens for the detection of IgG and IgG1 and IgG2 subclasses in the diagnosis of American tegumentary leishmaniasis in dogs.
    Ribeiro FC; de O Schubach A; Mouta-Confort E; Schubach TM; de Fátima Madeira M; Marzochi MC
    Vet Parasitol; 2007 Sep; 148(3-4):200-6. PubMed ID: 17689193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunopathological studies of Leishmania amazonensis infection in resistant and in susceptible mice.
    de Oliveira Cardoso F; de Souza Cda S; Mendes VG; Abreu-Silva AL; Gonçalves da Costa SC; Calabrese KS
    J Infect Dis; 2010 Jun; 201(12):1933-40. PubMed ID: 20462353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell response in murine Leishmania mexicana amazonensis infection: production of interferon-gamma by CD8+ cells.
    Chan MM
    Eur J Immunol; 1993 May; 23(5):1181-4. PubMed ID: 8097471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
    Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
    Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PD-L1 and PD-L2 have distinct roles in regulating host immunity to cutaneous leishmaniasis.
    Liang SC; Greenwald RJ; Latchman YE; Rosas L; Satoskar A; Freeman GJ; Sharpe AH
    Eur J Immunol; 2006 Jan; 36(1):58-64. PubMed ID: 16358363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp.
    Caballero ZC; Sousa OE; Marques WP; Saez-Alquezar A; Umezawa ES
    Clin Vaccine Immunol; 2007 Aug; 14(8):1045-9. PubMed ID: 17522327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response.
    Alexander J; Coombs GH; Mottram JC
    J Immunol; 1998 Dec; 161(12):6794-801. PubMed ID: 9862710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
    Iborra S; Soto M; Carrión J; Alonso C; Requena JM
    Vaccine; 2004 Sep; 22(29-30):3865-76. PubMed ID: 15364433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD; Locksley RM; Tubbs C; Raff HV
    J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterologous protection by Leishmania donovani for Leishmania major infections in the vervet monkey model of the disease.
    Gicheru MM; Olobo JO; Anjili CO
    Exp Parasitol; 1997 Feb; 85(2):109-16. PubMed ID: 9030661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An essential role for IL-13 in maintaining a non-healing response following Leishmania mexicana infection.
    Alexander J; Brombacher F; McGachy HA; McKenzie AN; Walker W; Carter KC
    Eur J Immunol; 2002 Oct; 32(10):2923-33. PubMed ID: 12355446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SCID mice reconstituted with IL-4-deficient lymphocytes, but not immunocompetent lymphocytes, are resistant to cutaneous leishmaniasis.
    Satoskar A; Brombacher F; Dai WJ; McInnes I; Liew FY; Alexander J; Walker W
    J Immunol; 1997 Nov; 159(10):5005-13. PubMed ID: 9366428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trypanosoma cruzi antigen-specific antibody response in immunized mice during acute and chronic infection.
    Mikhail KS; Rowland EC
    J Parasitol; 1990 Oct; 76(5):690-7. PubMed ID: 2120413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of DNA vaccines encoding various antigens against Leishmania mexicana.
    Dumonteil E; Andrade-Narvarez F; Escobedo-Ortegon J; Ramirez-Sierra MJ; Valencia-Pacheco G; Flores-Serrano A; Canto-Lara S; Arjona-Torres A
    Dev Biol (Basel); 2000; 104():135-41. PubMed ID: 11713811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of different Leishmania spp. and Trypanosoma cruzi antibodies in cats from the Yucatan Peninsula (Mexico) using an iron superoxide dismutase excreted as antigen.
    Longoni SS; López-Cespedes A; Sánchez-Moreno M; Bolio-Gonzalez ME; Sauri-Arceo CH; Rodríguez-Vivas RI; Marín C
    Comp Immunol Microbiol Infect Dis; 2012 Sep; 35(5):469-76. PubMed ID: 22560557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.
    Iborra S; Carrión J; Anderson C; Alonso C; Sacks D; Soto M
    Infect Immun; 2005 Sep; 73(9):5842-52. PubMed ID: 16113303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin.
    Mukherjee M; Bhattacharyya A; Duttagupta S
    Med Sci Monit; 2002 Apr; 8(4):BR117-22. PubMed ID: 11951057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.